Directors' Dealings

RNS Number : 8749P

Accrol Group Holdings PLC

01 June 2018

 

1 June 2018

ACCROL GROUP HOLDINGS PLC
(AIM: ACRL)

Directors' Dealings

 Accrol Group Holdings plc ("Accrol" or the "Company"), the leading independent tissue converter in the UK, is pleased to announce that certain directors of Accrol have, pursuant to the placing to raise £8.0 million (before expenses) described in the Company's announcement of 15 May 2018 titled "Proposed Placing to raise £8 million", in aggregate purchased 2,133,332 ordinary shares of £0.001 each ("Ordinary Shares") at a price of 15p per Ordinary Share as set out below.

Name	Title	Number of Shares	Value of Shares	Resulting Shareholding	Percentage of Enlarged Share Capital
Daniel Wright	Executive Chairman	1,333,333	£200,000	1,748,501	0.96%
Gareth Jenkins	Chief Executive Officer	500,000	£75,000	600,000	0.33%
Martin Leitch	Interim Chief Financial Officer	266,666	£40,000	266,666	0.15%
Joanne Lake	Non-executive Director	33,333	£5,000	68,333	0.04%

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	i)             Dan Wright ii)            Gareth Jenkins iii)          Martin Leitch iv)           Joanne Lake
2	Reason for the notification
a)	Position/status	i)            Executive Chairman ii)           Chief Executive Officer iii)          Chief Financial Officer iv)           Non-executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Accrol Group Holdings plc
b)	LEI	213800MC56M5G69RJ226
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.001 ISIN: GB00BZ6VT592
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) 15p	Volume(s) i) 1,333,333 ii) 500,000 iii) 266,666 iv) 33,333
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	1 June 2017
f)	Place of the transaction	London Stock Exchange, AIM

Enquiries:

Zeus Capital Limited (Nominated Adviser & Broker)
Dan Bate / Andrew Jones	Tel: [phone]
Dominic King / John Goold	Tel: [phone]
Belvedere Communications Limited
Cat Valentine ([e-mail])	Mob: [phone]

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to major retailers throughout the UK. 

Accrol operates from three sites:

·      A manufacturing, storage and distribution facility in Blackburn;

·      A facial tissue plant, also in Blackburn; and

·      A manufacturing, storage and distribution facility in Leyland.

 

END

 

 

DSHGMGFKZMDGRZM